The inverse correlation between BAT and body weight or glucose levels has made BAT an attractive target in the therapeutic management of metabolic disorders, to enhance insulin sensitivity [33] and to lower the susceptibility for development of obesity [34]. This evidence concerns the gene INS and metabolic disease.